Interventions: Drug: Semaglutide Drug: Placebo (semaglutide) Primary Outcome Measures Change in maximum walking distance on a constant load treadmill test Ratio to baseline Time frame - From baseline (week 0) to end of treatment (week 52) In light of the STRIDE trial results, Novo Nordisk has submitted a label extension application for Ozempic to the U.S
Maternal obesity increases the risk for congenital malformations, including neural tube defects, cardiac malformations, oral clefts, and limb reduction defects
At age 20, plasma levels average around 200 ng/mL
Insulin-Like Growth Factor-1 Long R3 (IGF-1 LR3) is a synthetic analog of IGF-1, a natural hormone that plays a crucial role in growth and development
Neem nooit twee doses in om een gemiste dosis in te halen
Aplicar una compresa fra (no hielo directo) durante 5-10 minutos despus de la inyeccin puede proporcionar alivio